{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:10:36Z","timestamp":1792757436931,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3037,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.fertnstert.2013.10.048","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T02:30:15Z","timestamp":1386729015000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Influence of tumor necrosis factor \u03b1 inhibitors on testicular function and semen in spondyloarthritis patients"],"prefix":"10.1016","volume":"101","author":[{"given":"Roberta","family":"Ramonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Foresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusta","family":"Ortolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Lorenzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Pizzol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.10.048_bib1","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3899\/jrheum.120107","article-title":"Anterior chest wall involvement in early stages of spondyloarthritis: advanced diagnostic tools","volume":"39","author":"Ramonda","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib2","first-page":"1649","article-title":"Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men","volume":"17","author":"Will","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11926-013-0317-3","article-title":"Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis","volume":"15","author":"Taylor","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridizationtechniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Brown","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: arandomized controlled multicenter trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib9","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","article-title":"Recombinant human tumor necrosis factor eceptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial","volume":"48","author":"Davis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib10","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/ard.2006.056747","article-title":"Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis","volume":"65","author":"van der Hejide","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib11","first-page":"992","article-title":"Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long term results from the ATLAS trial","volume":"68","author":"Van der Hejide","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/03009742.2012.698393","article-title":"Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study","volume":"4","author":"Modesti","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/08923973.2011.653646","article-title":"Safety of anti-TNF\u03b1 agents in the treatment of psoriasis and psoriatic arthritis","volume":"34","author":"Girolomoni","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/120347541201600305","article-title":"Biologic therapy in psoriasis: perspectives on associated risks and patient management","volume":"16","author":"Papp","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/s10165-012-0712-z","article-title":"Angioimmunoblastic T cell lymphoma in an ankylosing spondylitis patient treated with etanercept","volume":"23","author":"Jung","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-Cell non-hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-\u03b1) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib20","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/ard.2009.111500","article-title":"Demyelinating events in rheumatoid arthritis after drug exposures","volume":"69","author":"Bernatsky","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/rheumatology\/kes114","article-title":"Assessing the safety of biologic agents in patients with rheumathoid arthritis","volume":"51","author":"Rubbert-Roth","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/rheumatology\/kep083","article-title":"Paradoxical adverse events of antitumour necrosis factor therapy for spondyloarthropathies: a retrospective study","volume":"48","author":"Fouache","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1684\/ejd.2010.1235","article-title":"Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers","volume":"21","author":"Lo Nigro","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib24","first-page":"273","article-title":"Adverse reactions during biological drug therapy in psoriasis: clinical series and a review of the literature","volume":"146","author":"Montesu","year":"2011","journal-title":"Ital Dermatol Venereol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.anai.2011.11.004","article-title":"Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab","volume":"108","author":"Puxeddu","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0190-9622(93)70270-4","article-title":"Methotrexate and reproduction in men: case report and recommendation","volume":"29","author":"Morris","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/gut.22.6.445","article-title":"Sulphasalazine and male infertility: reversibility and possible mechanism","volume":"22","author":"Toovey","year":"1881","journal-title":"Gut"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.reprotox.2006.04.020","article-title":"Progress in the development of childhood cancer therapy","volume":"22","author":"Garolla","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0015-0282(16)44000-8","article-title":"Reversible toxic effect of salicylazosulfapyridine on semen quality","volume":"31","author":"Toth","year":"1979","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00108-012-3028-3","article-title":"Rheumatic diseases with primary onset in young adults: spondyloarthritis and connective tissue diseases","volume":"53","author":"Max","year":"2012","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib31","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib32","first-page":"S64","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib34","article-title":"WHO laboratory manual for the examination and processing of human semen","year":"2010"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2012.09.006","article-title":"Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patients","volume":"99","author":"Garolla","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14737159.1.1.81","article-title":"Universal Linkage System: versatile nucleic acid labeling technique","volume":"1","author":"van Gijlswijk","year":"2001","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1530\/eje.0.1510629","article-title":"Tumor necrosis factor alpha (TNF alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist","volume":"15","author":"Suominen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib38","first-page":"1665","article-title":"Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model","volume":"6","author":"Tamer","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jbspin.2012.03.004","article-title":"Fertility in male patients with seronegative spondyloarthropaties treated with infliximab","volume":"80","author":"Saougou","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3899\/jrheum.080554","article-title":"Fertility and reproduction in male patients with ankylosing spondylitis treated with Infiliximab","volume":"36","author":"Paschou","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib41","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/ard.2005.038620","article-title":"Asthenoazoospermia in patients receiving anti tumor necrosis factor alpha agents","volume":"64","author":"la Montagna","year":"2005","journal-title":"Ann Reum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.MIB.0000164023.10848.c4","article-title":"Infliximab and semen quality in men with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib43","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2009.127423","article-title":"Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis","volume":"69","author":"Villiger","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/03009742.2012.688218","article-title":"Gonadal function in male patients with ankylosing spondylitis","volume":"41","author":"Nukumizu","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib45","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/MCB.24.7.2593-2604.2004","article-title":"Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytochine tumor necrosis factor alpha","volume":"24","author":"Hong","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib46","first-page":"2414","article-title":"Testosterone and testosterone free index in mild ankylosing spondylitis: relationship with bone mineral density and vertebral fractures","volume":"26","author":"Mitra","year":"1999","journal-title":"Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib47","first-page":"969","article-title":"Androgens and ankylosing spondylitis: a role in the pathogenesis?","volume":"26","author":"Giltay","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib48","first-page":"2236","article-title":"Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoproteogirin serum levels in patients with ankylosing spondylitis","volume":"31","author":"Franck","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10067-004-1039-8","article-title":"Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis","volume":"24","author":"el Maghraoui","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.fertnstert.2013.10.048_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.2005.02369.x","article-title":"Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels","volume":"63","author":"Aydin","year":"2005","journal-title":"Clin Endocrinol"}],"updated-by":[{"DOI":"10.1016\/j.fertnstert.2014.02.018","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000}}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213032111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213032111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:58:57Z","timestamp":1773251937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213032111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0015028213032111"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.10.048","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of tumor necrosis factor \u03b1 inhibitors on testicular function and semen in spondyloarthritis patients","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}